Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Drdgold (DRD) Liabilities and Shareholders Equity (2017 - 2025)

Drdgold (DRD) has disclosed Liabilities and Shareholders Equity for 9 consecutive years, with $670.6 million as the latest value for Q2 2025.

  • Quarterly Liabilities and Shareholders Equity rose 31.66% to $670.6 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 billion through Jun 2025, up 11.96% year-over-year, with the annual reading at $670.6 million for FY2025, 31.66% up from the prior year.
  • Liabilities and Shareholders Equity hit $670.6 million in Q2 2025 for Drdgold, up from $509.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $670.6 million in Q2 2025 to a low of $438.4 million in Q2 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $504.8 million across 5 years, with a median of $456.7 million in 2022.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 41.64% in 2021 and later dropped 4.02% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $448.9 million in 2021, then rose by 1.74% to $456.7 million in 2022, then decreased by 4.02% to $438.4 million in 2023, then grew by 16.18% to $509.3 million in 2024, then surged by 31.66% to $670.6 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for DRD at $670.6 million in Q2 2025, $509.3 million in Q2 2024, and $438.4 million in Q2 2023.